I enclose below our first announcement on the program for our eCheminfo Autumn Community of Practice meeting on Drug Discovery & Development which will be held at Bryn Mawr the week of October 15. Included are descriptions of programs, workshops and forums, a CFP and information on Bursary Awards.
The conference program will cover Structure-based Drug Design, chaired by Jose Duca (Schering- Plough), Fragment-based Drug Discovery, chaired by Maria Kontoyianni (Crystax Pharmaceuticals), Structural Biology, chaired by Max Cummings (Johnson & Johnson PR&D) and Predictive ADME/Toxicology, chaired by Tony Hopfinger (University of New Mexico College of Pharmacy).
A variety of workshops will be held throughout the meeting. The approach will be hands-on using an IT classroom and a set of workshops led by application scientists using leading drug discovery software packages.
The following two forums will be held at the meeting:
* Virtual Screening & Docking - Comparative Methodology & Best Practice
* Forum & Workshop on International Cooperation in ADME/Tox
Early registration runs through end of June.
best regards
Barry Hardy
Community of Practice Manager
Douglas Connect
Switzerland
Tel: +41 61 851 0170
Latest Advances in Drug Discovery & Development
15-18 October 2007
Community of Practice Meeting, Autumn 2007
a joint InnovationWell and eCheminfo InterAction Meeting
Bryn Mawr College, Philadelphia
http://www.echeminfo.com/COMTY_conferences
(Last year's agenda is given at
http://www.echeminfo.com/comty_conferenceprogram)
eCheminfo Program
The program will consist of two primary components, seminar sessions and workshops, accompanied by a significant amount of discussion and networking activity. A focus of this meeting is to present and discuss research involving methods and practical approaches which the attendees will be able to take back to their labs and apply to their projects. Last year's sessions were well attended and evaluated with a mix of industry case-studies and applications, discussion of methods and results and incorporation of the medicinal/synthetic chemistry element with great emphasis on scientific discussions.
The seminar program will have four main conference sessions:
Structure-based Drug Design, chaired by Jose Duca (Schering-Plough)
Fragment-based Drug Discovery, chaired by Maria Kontoyianni (Crystax Pharmaceuticals)
Structural Biology, chaired by Max Cummings (Johnson & Johnson PR&D)
Predictive ADME/Toxicology, chaired by Tony Hopfinger (University of New Mexico College of Pharmacy)
Confirmed Invited Speakers for eCheminfo Program (Preliminary List)
Stephen Burley (SGX Pharmaceuticals), Georgia McGaughey (Merck), Charles Lesburg (Schering-Plough), Woody Sherman (Schrodinger), Daniel Cheney (Bristol Myers Squibb), Paul Labute (Chemical Computing Group), Ajay Jain (UCSF), Alan Cheng (Amgen), Tony Hopfinger (University of New Mexico), Anthony Klon (Pharmacopeia Drug Discovery), Artem Cherkasov (University of British Columbia), Dennis Pelletier (Pfizer), Chaohong Sun (Abbott), Xavier Barril (University of Barcelona), Jose Duca (Schering-Plough), Terry Stouch
Workshops
A variety of workshops will be held throughout the meeting. The approach will be hands-on using an IT classroom and a set of workshops led by application scientists using leading drug discovery software packages. Each workshop will be accompanied by practitioner-led discussions of the methods worked on by the group.
Topics to be covered: Virtual Screening & Docking; Structure-based Drug Design; Ligand Optimisation & Library Design; Structure Search, Similarity and Property Estimation; Data Mining, Analysis & Visualisation; Integration of Cheminformatics & Bioinformatics Tools & Data; Latest advances in ADME & Predictive Toxicology; Pharmacokinetics & Pharmacodynamics and Physiological-based Simulation.
Forums
The following two forums will be held during the meeting:
A. Mon Oct 15th -
Virtual Screening & Docking - Comparative Methodology & Best
PracticeMore Information at: http://barryhardy.blogs.com/cheminfostream/2007/03/virtual_screeni.htmlB. Thursday, Friday Oct 18th,19th -
Forum & Workshop on International Cooperation in ADME/Tox
More Information at: http://barryhardy.blogs.com/cheminfostream/2007/03/international_c.htmlInnovationWell program
http://innovationwell.net/
In our initial community of practice meetings including our InnovationWell meeting last October at Bryn Mawr, Philadelphia we have discussed recent and coming developments of relevance to drug, life science and healthcare product development, drug and patient safety and translational medicine.
This year�s InnovationWell program at Bryn Mawr will have themes running throughout the meeting covering areas of innovation (systems biology, toxicology, metabolomics, biomarkers, diagnostics, emerging biotech & nanotech, knowledge management) and which will have a second topic division by session in terms of therapeutic area (diabetes, oncology, cardiology, anti-inflammatory, anti-viral). Each session will include discussion leadership from a therapeutic specialty providing a clinical perspective on the deployment and integration of emerging areas of life science, diagnostics and knowledge management technologies so as to progress Critical Path goals in clinical development and safety.
Call for Contributed Talks & Posters to eCheminfo Program
We invite contributed papers from members of academic, government research and commercial organizations on areas of new research and innovation involving drug discovery research informatics. The work presented should involve innovative new method development or application to drug discovery problems and involving methods from computational chemistry, computational biology, cheminformatics or bioinformatics. Studies including experimental work in medicinal chemistry, screening, experimental toxicology, pre-clinical evaluation, lead optimisation and translational medicine are welcome.
Abstracts (300-500 words) should be submitted to echeminfo -[at]- douglasconnect.com by 30 April 2007, and be accompanied by a short biography of the presenting author (300-500 words). Abstracts approved by the scientific organizing committee will be selected for scheduling on the conference program and in meeting poster sessions. Authors will be notified of acceptance by 31 May.
Bursary Awards for eCheminfo Program
Bursary Awards will be used to support the attendance of a selection of academic young investigators at the meeting and workshops. Applicants can be working in any area of research related to drug discovery at the postdoctoral, graduate student and senior undergraduate levels.
To apply for the bursary please send an email with a) your abstract and biography (300-500 words each), b) your CV of 1-2 pages, c) a short description of your interests and career motivations related to drug discovery (300-500 words) to echeminfo -[at]- douglasconnect.com by 30 April 2007. The recipients of the bursary awards will be selected based on an evaluation of the quality and innovation of the described research and the potential positive impact of attendance at the meeting on their research and career progress. Recipients will be notified of acceptance by 31 May.
Barry Hardy
Community of Practice Manager
Douglas Connect
Switzerland
Tel: +41 61 851
0170
